Skip to main content

Aspiriant, LLC

SEC CIK
0001433541
Latest filing
Jul 20, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
10,553
Value
$2.66M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Aspiriant, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202610,553$2.66M0.1%+818+8.4%AddedHolders
Q1 20269,735$2.12M0.1%+293+3.1%AddedHolders
Q4 20259,442$2.16M0.1%+207+2.2%AddedHolders
Q3 20259,235$2.14M0.1%+839+10.0%AddedHolders
Q2 20258,396$1.56M<0.1%−107−1.3%ReducedHolders
Q1 20258,503$1.78M0.1%−274−3.1%ReducedHolders
Q4 20248,777$1.56M0.1%+412+4.9%AddedHolders
Q3 20248,365$1.65M0.1%−133−1.6%ReducedHolders
Q2 20248,498$1.46M0.1%−767−8.3%ReducedHolders
Q1 20249,265$1.69M0.1%+260+2.9%AddedHolders
Q4 20239,005$1.40M0.1%−216−2.3%ReducedHolders
Q3 20239,221$1.37M0.1%−26−0.3%ReducedHolders
Q2 20239,247$1.25M0.1%+379+4.3%AddedHolders
Q1 20238,868$1.41M0.1%+384+4.5%AddedHolders
Q4 20228,484$1.37M0.1%+502+6.3%AddedHolders
Q3 20227,982$1.07M0.1%−8,632−52.0%ReducedHolders
Q2 202216,614$2.54M0.1%+55+0.3%AddedHolders
Q1 202216,559$2.68M0.1%+8,999+119.0%AddedHolders
Q4 20217,560$1.02M0.1%+227+3.1%AddedHolders
Q3 20217,333$791.0K<0.1%−6−0.1%ReducedHolders
Q2 20217,339$827.0K<0.1%−74−1.0%ReducedHolders
Q1 20217,413$801.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.